CUSIP: 69353Y103
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
53,185,766
-
Total 13F shares
-
37,422,687
-
Share change
-
-94,369
-
Total reported value
-
$46,777,977
-
Price per share
-
$1.25
-
Number of holders
-
62
-
Value change
-
-$174,801
-
Number of buys
-
30
-
Number of sells
-
27
Quarterly Holders Quick Answers
What is CUSIP 69353Y103?
CUSIP 69353Y103 identifies PMVP - PMV Pharmaceuticals, Inc. - COMMON STOCK in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Previous quarter:
Q3 2025
Recent filing periods for CUSIP 69353Y103:
Institutional Holders of PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) as of Q4 2025
As of 31 Dec 2025,
PMV Pharmaceuticals, Inc. - COMMON STOCK (PMVP) was held by
62 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,422,687 shares.
The largest 10 holders included
BML Capital Management, LLC, ORBIMED ADVISORS LLC, TANG CAPITAL MANAGEMENT LLC, ArrowMark Colorado Holdings LLC, Sio Capital Management, LLC, Euclidean Capital LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Stonepine Capital Management, LLC, and BlackRock, Inc..
This page lists
62
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.